Activity lecture location:HomeActivity lectureDetails

The first working meeting of the Psoriasis Professional Committee of the Dermatology and Venereology Branch of the Chinese Medical Association in 2023 was successfully held

Source:Institute of Dermatology, Ann Medical University    Date:2023/03/06    Browse:1719 second

On the morning of March 5, 2023, the first working meeting of the Psoriasis Professional Committee of the Dermatology Branch of the Chinese Medical Association in 2023 was successfully held online. The meeting invited Professor Lu Qianjin, chairman of the Dermatology Branch of the Chinese Medical Association, Professor Cui Yong, vice president of the Dermatology and Skin Cosmetology Branch of the Chinese Medical Equipment Association, and the leader of the Psoriasis Group of the Dermatology Branch of the Chinese Medical Association. Deputy group leader and committee member, director and committee member of the sub-center of Psoriasis Research Center, head of psoriasis clinic, member of Global Psoriasis Surveillance (GPA) China Committee, editorial board member of China Psoriasis Diagnosis and Treatment Guidelines, representatives of related companies Nearly 300 people participated.

001.jpg

Group photo of some participants

The meeting was co-chaired by Professor Zhang Chunlei and Professor Li Yuzhen, deputy directors of the Psoriasis Group of the Dermatology and Venereology Branch of the Chinese Medical Association.

002.jpg

                                Professor Li Yuzhen

The team leader Zhang Xuejun first introduced the 2022 work summary and 2023 work plan of the Psoriasis Special Committee. Reviewed the compilation process, published the 2022 edition of "Guidelines for Primary Diagnosis and Treatment of Psoriasis", "Expert Consensus on the Application of Methotrexate in the Treatment of Psoriasis"; successfully held the 6th China Psoriasis Conference, and newly awarded 35 banks Psoriasis outpatient clinics have brought the total number of psoriasis outpatient clinics across the country to 350. In 2022, the psoriasis group will diagnose and treat 710,000 patients with psoriasis; publish 311 papers on psoriasis, including 133 SCI papers; edit and write 27 monographs on psoriasis per person; The research results won 1 national award and 4 provincial and ministerial awards; carried out more than 886 psoriasis dandelion actions/patient education, benefiting 720,000 person-times; edited 35 psoriasis-related guidelines/consensus/person-times; won the National Invention Award 23 patents. Professor Zhang Xuejun also listed the work plan for 2023: continue to promote the establishment of dermatology psoriasis specialty clinics and demonstration clinics nationwide, and make them an important task of the special committee; increase efforts to promote the continued development of China's GPA project; Completed the publication of the 2022 edition of the "Guidelines for Diagnosis and Treatment of Psoriasis in China"; launched the English monograph on psoriasis psoriasis comorbidity treatment expert consensus Compilation of grassroots guidelines for psoriasis targeted therapy, so that more members of the psoriasis special committee can be selected to join in the compilation work; promote international cooperation, connect with IPC activities, and recommend new IPC members; promote the development of the Thousand Counties No Bank Project Cooperate with psoriasis in research projects; carry out psoriasis science education activities; hold the 7th China Psoriasis Conference, and continue to promote the prevention, diagnosis and treatment of psoriasis in China. This is also one of the most important tasks this year. You can work together with the society to hold the conference well. During the psoriasis conference, hundreds of famous doctors and thousands of psoriasis patients will hold popular science free consultation activities, which is of great significance to promote the development of psoriasis chronic disease management and prevention in my country. It is hoped that through the national policies in the next five years, the joint efforts of doctors and business colleagues will improve the happiness index of psoriasis patients in my country to 90%. In the end, we will realize the good treatment effect of psoriasis patients, the confidence of doctors in treatment, the guarantee of the business of pharmaceutical enterprises, and the vision of healthy China.

Picture 7.png

Professor Zhang Xuejun

Professor Lu Jinjin, chairman of the Dermatology and Venereology Branch of the Chinese Medical Association, then delivered a speech. Professor Lu first pointed out that psoriasis is an important and common disease in dermatology. medical services to improve the quality of life of patients. On behalf of the sub-committee, Professor Lu fully affirmed and thanked the Psoriasis Special Committee headed by Zhang Xuejun for a lot of work in psoriasis diagnosis and treatment, scientific research, guideline compilation, popular science, academic exchanges and other aspects in the past few years, and achieved fruitful results The achievements have significantly improved the diagnosis and treatment capabilities and international influence of Chinese dermatologists in psoriasis, and made important contributions to the prevention, diagnosis and treatment of psoriasis patients and the improvement of their happiness index. The Psoriasis Special Committee has made careful arrangements for the work in 2023, and continues to promote the work of the Psoriasis Special Committee, including academic exchanges, licensing of specialized disease clinics and demonstration clinics, continuation of the GPA project, revision and publication of guideline consensus , International cooperation docking IPC activities, standardizing grassroots diagnosis and treatment activities, popular science education, etc. I believe that under the leadership of Professor Zhang Xuejun and the joint efforts of all experts and professors, new results will be achieved in the work in 2023, providing more accurate and high-quality diagnosis and treatment services for the majority of psoriasis patients, and improving the overall quality of psoriasis in my country. The level of disease diagnosis and treatment and international influence.

Picture 8.png

Professor Lu Jinjin

Deputy team leader Professor Zheng Min then introduced the experience of participating in the academic activities of IPC in 2022 and the academic activities that CPC will participate in in 2023. Professor Zheng introduced the five aspects that IPC will focus on in 2022, including disease improvement of psoriasis and its comorbidities, pathological mechanism of psoriatic disease memory, early intervention and disease improvement, diversity and psoriasis, Perspectives on the long-term management of psoriasis; and introduced the current new chair of the IPC, Professor Hervé Bachelez. Finally, Professor Zheng pointed out how our Psoriasis Special Committee can play a better role by studying IPC. First, we must conscientiously fulfill our CPC mission in China. The materials of each CPC annual meeting and the materials of psoriasis GPA China activities are translated. It is easy to communicate with Chinese and English, and enhance the influence of my country's CPC; secondly, how to play a better role in leading the academic activities of inflammatory skin diseases in China through IPC exchanges, we should introduce it to domestic dermatologists in time IPC's latest academic progress and actively participate in their academic activities and conferences, cooperate with academic research, and continuously improve our own academic level. Finally, we must actively participate in the work and meetings that IPC participates in: IPC requires our directors and domestic CPC leaders to participate in their activities in international conferences, and IPC seminars are involved in each of the following conferences, such as AAD, TIID (Tokyo, Japan) , WCD (Singapore), EADV, IPC Think Tank (USA), etc.

Picture 9.png

Professor Zheng Min

Professor Shi Yuling, deputy team leader, introduced the science education of psoriasis. First, she pointed out that science education activities are highly valued by the country and dermatologists. quality. Professor Shi summarized the "Dandelion Action" popular science education for psoriasis patients carried out by the Psoriasis Special Committee in the past few years. Based on the popular science book "Psoriasis Interpretation" published by the With the participation of members and various experts and professors, during the past few psoriasis conferences, large-scale public welfare free clinic activities for hundreds of famous doctors and thousands of psoriasis patients, 2022 World Psoriasis Day science popularization activities, and the 6th CPC Science Popularization-To The net new life charity trip, Dandelion Action - chronic skin disease science popularization health plan, psoriasis series of public welfare activities and GPA activities popular science education; in the past three years of the epidemic, the special committee still has not given up on popular science education activities, and more popular science education is online It was carried out online, and more expert directors and grassroots doctors participated in the activity. Professor Shi introduced that in 2023, the special committee will carry out popular science education activities on dandelion psoriasis, including 100 free consultations and health consultations for county-level dermatology patients in Qianxian County, as well as compiling "Psoriasis Interpretation" on the basis of the popular science book "Psoriasis Interpretation". Psoriasis Science Education Guide, I believe that with the joint efforts of all comrades, it will definitely benefit the psoriasis patients in our country.

Picture 10.png

Professor Shi Yuling

Professor Zhang Xibao, consultant of the academic group, introduced the guidelines, consensus and follow-up writing plan for psoriasis, which mainly includes three parts. First, the 2022 edition of the guidelines for diagnosis and treatment of psoriasis in China will start from July 2021 to December 2022 Released and revised at the end of February 2023. So far, the work of the diagnosis and treatment guideline has been basically completed. It is believed that the official publication can be completed in the next two to three months. The whole guideline has 103 pages, 79,000 words, and 338 references; the second is preparation Write an English monograph on psoriasis, and share the experience and methods of diagnosis and treatment of psoriasis in China with the international community. The work is currently under preparation and improvement. It is planned to write 19 chapters, 300 pages of English monographs, and carry out the division of labor for the entire monograph. Third, with the clinical needs of psoriasis comorbidities, science popularization, chronic disease management, etc., the guideline consensus that the special committee is working on in 2023 includes: psoriasis comorbidity treatment expert consensus, psoriasis science education guideline, psoriasis Expert consensus on chronic disease management, psoriasis skin barrier repair expert consensus, and grassroots guidelines for psoriasis targeted therapy. The editorial board members of these guideline consensus will be selected from the psoriasis guideline editorial board, GPA China Committee, and grassroots specialized disease clinics. doctor. It is hoped that through the joint efforts of all of you, the compilation of monographs, guidelines and consensus will be completed, so as to further meet the clinical needs of dermatologists and psoriasis patients in my country.

Picture 11.png

Professor Zhang Xibao

Professor Cui Yong, vice president of the Dermatology and Skin Cosmetology Branch of the China Medical Equipment Association, was invited to participate in this meeting, and introduced the ongoing Qianxian County No Silver-Psoriasis Grassroots Standardized Diagnosis and Treatment Capacity Improvement Project. The project is guided by the Talent Exchange Service Center of the National Health and Medical Commission, the China Medical Equipment Association and Suzhou University are the sponsors, and the Psoriasis Special Committee of the Dermatology and Venereology Branch of the Chinese Medical Association is the co-organizer. With the help of the "Guidelines for the Primary Care Diagnosis and Treatment of Psoriasis" (2022 Edition), standardize the treatment of psoriasis and other common dermatological diseases in primary hospitals to improve the quality of life and happiness index of patients with skin diseases. The project includes 6 national tours, 72 provincial tours, 216 county tours, and 2,000 hospital tours. With the development of the whole project, the grassroots dermatology hospitals and doctors who actively participate will be expected to be awarded the psoriasis outpatient clinic, Qianxian Wuyin-County Psoriasis Treatment Base, and pass the standardized training assessment issued by the National Health and Medical Commission Certificate, you can also participate in the Ministry of Education Key Laboratory of psoriasis epidemiological research and biological treatment efficacy research projects, to further improve the level of clinical diagnosis and research at the grassroots level.

Picture 12.png

Professor Cui Yong

Professor Sun Liangdan, director of the Psoriasis Research Center, introduced the work report of the Global Psoriasis Surveillance Project (GPA), pointing out that GPA will become an important source of global psoriasis epidemiological resources, and provide a basis for research, policy and Health care provides information. Introduced the current epidemiological data and development of psoriasis in the world, as well as the four key research areas of GPA: psoriasis epidemiology, psoriasis economic impact, psoriasis comorbidity burden, improving psoriasis GPA has published relevant research papers such as "Dichotomy", "Epidemiology" and so on; Professor Sun introduced the development of CGPA and sample collection in China, including the current sample size, male-to-female ratio, average age of onset, Medical insurance information, concomitant diseases, etc., also shared the benefits and results of participating in CGPA activities; in 2023, we will continue to rely on 350 specialized disease clinics across the country to speed up sample collection, hold 15-20 guide tour lectures and popular science education activities, and promote banking New technologies and new concepts of psoriasis diagnosis and treatment, strengthen international cooperation, and strive to build a new epidemiological map of the Chinese population as soon as possible. At the same time, the 2023 GPA notice and investment invitation letter were released. Finally, Professor Sun thanked the units that participated in the collection of CGPA samples and the enterprises that supported the CGPA project activities. I also hope that in the future, the Psoriasis Special Committee will work together to promote the development of GPA and CGPA based on public welfare and a long-term basis, so as to improve the level of prevention, diagnosis and treatment of psoriasis in my country.

Picture 13.png

Professor Sun Liangdan

Professor Tang Huayang, secretary-general of the 7th China Psoriasis Conference, summarized the successful holding of the 6th China Psoriasis Conference in 2022. The conference invited 77 speakers and moderators, including academicians, foreign speakers, domestic experts and professors, Released the "Guidelines for the Diagnosis and Treatment of Psoriasis in China" (2022 Edition) and the Chinese expert consensus on the treatment of psoriasis biological agents to meet the standards; released the open project "Research on Standardized Diagnosis and Treatment of Psoriasis and Chronic Disease Management" by the Key Laboratory of Dermatology, Ministry of Education ; Selected 10 psoriasis model outpatient units and 11 excellent free clinic units on World Psoriasis Day; awarded 35 psoriasis specialized outpatient units; made outstanding contributions to 4 in the field of psoriasis research scholars were honored. He also reported on the preparations for the 7th China Psoriasis Conference, pointing out that this year will be held in accordance with the offline scale of the previous three conferences, and 500-1000 people will attend the conference offline, and the conference will be broadcast live simultaneously online; this conference will have national continuing education 6 credits; add a free submission link; select the top ten most influential psoriasis academic papers; carry out psoriasis science popularization, 100 famous doctors and 1,000 psoriasis patients charity free clinic activities; publish psoriasis-related consensus and guidelines; Psoriasis Specialized Outpatient Clinic awarded licenses and awards. Finally, Secretary-General Tang welcomed the professional committee and business colleagues to actively participate in the 7th China Psoriasis Conference, and work together to make important contributions to the development of psoriasis chronic disease management, prevention, diagnosis and treatment in my country.

Picture 14.png

Professor Tang Huayang

Finally, Professor Zhang Xuejun summed up this working meeting, pointing out that this meeting has been highly valued by the branch, and it is a practical meeting that summarizes the past, looks forward to the future, and has clear goals. In this working meeting, international cooperation, IPC docking, psoriasis science popularization, guideline consensus compilation, Qianxian County No Silver-Psoriasis Grassroots Standardized Diagnosis and Treatment Ability Improvement Project, GPA plan work report, preparations for the 7th China Psoriasis Conference etc. to plan and deploy the prevention, diagnosis and treatment of psoriasis and the promotion of international influence from all aspects. In order to implement the spirit of healthy China during the 14th Five-Year Plan period, we call on the Psoriasis Committee of the Dermatology Branch of the Chinese Medical Association, the Psoriasis Committee of the Dermatologist Branch of the Chinese Medical Doctor Association, and the Psoriasis Group of the Rehabilitation Medicine Association. The joint efforts of the organization, more free clinics, popular science publicity and standardized diagnosis and treatment have further improved the level of diagnosis and treatment of psoriasis in my country, thereby improving the happiness index of Chinese psoriasis patients. Although the Psoriasis Special Committee has made a lot of achievements in the past, such as China’s contribution to psoriasis genetics was recognized in the International Lancet, but the overall contribution to psoriasis research and diagnosis and treatment is relatively low compared to the international community. Said that there is still a large gap. It is hoped that the national psoriasis research team will continue to work hard, make more achievements, and generally improve my country's international influence and the level of psoriasis prevention, diagnosis and treatment.

Picture 15.png

Professor Zhang Xuejun

Photo and text Zhu Zhengwei

March 5, 2023


China Psoriasis Network CPC2020

Xu Xiangmei (Conference consultation)
Mobile:15005604686
Email:1225856963@qq.com
Zhu Xiaofeng (Registration consulting)
Mobile:15156991066
Email:307676249@qq.com

Copyright: China Psoriasis Network Wanicp Bei 11019793 皖公网安备 34019202000792号